Loading data for HIMS — first visit, this takes a few seconds.

Preisalarm

Hims & Hers Health Inc. (HIMS)

NYSE: HIMS · Echtzeitkurs · USD

28.61

+0.46 (1.63%)

Zum Schluss: Aug 17, 2026, 8:00 PM

28.69

+0.28%

Nachbörslich: 7:59 PM

1.63% (1D)

Keine Daten verfügbar

Geld	n/a
Marktkapitalisierung	6.68 Mrd
Umsatz (TTM)	2.58 Mrd
Nettogewinn (TTM)	-142.03 Mio
Beta	2.42
EPS (ttm)	-0.64
KGV (TTM)	n/a
Forward-KGV	22.69
KBV (TTM)	20.60
KUV (TTM)	2.59
Earnings Date	Nov 9, 2026

Brief	n/a
Volumen	10,316,072
Ø Vol. (20D)	16,775,124
Eröffnung	28.14
Vortagesschluss	28.15
Tagesspanne	27.51 - 28.73
52-Wk Range	13.74 - 65.30
Analyst	n/a
Kursziel	n/a
Dividenden	n/a
Ex-Dividenden-Datum	n/a

Über HIMS

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by...

[Mehr lesen]

Branche Drug Manufacturers - Specialty & Generic

Sektor Healthcare

IPO Datum Sep 13, 2019

Mitarbeiter 2,442

Börse NYSE

Tickersymbol HIMS

Website https://www.hims.com

Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr 2025 betrug der Umsatz von Hims & Hers Health 2.35 Mrd, ein Anstieg von 59% im Vergleich zum Vorjahr (1.48 Mrd). Der Gewinn lag bei 128.37 Mio, ein Anstieg von 1.85 %.

Finanzberichte

Gewinnüberraschung

Hims & Hers Health hat die Quartalszahlen am Aug 10, 2026 veröffentlicht:

Umsatz von $608.1 Mio verfehlt die Erwartungen um $0, mit 3.77% Wachstum im Jahresvergleich.

EPS von -0.37 verfehlt die Erwartungen um -0.32, mit -227.59% Rückgang im Jahresvergleich.

Nächste Ergebnisveröffentlichung

Hims & Hers Health Inc. wird voraussichtlich die Quartalszahlen veröffentlichen am Nov 9, 2026, während der Handelszeiten.
Analysten erwarten einen Umsatz von ... Upgrade

Nachrichten

vor 16 Stunden · Quartz

Hims & Hers CEO Andrew Dudum pushes back on FTC lawsuit

Andrew Dudum told CNBC the agency wanted "more of a headline than a real agreement" after years of cooperative talks

vor 17 Stunden · Stocktwits

Hims & Hers CEO Andrew Dudum Says AI Health Coach Could Be Just 12 Months Away, Believes It Could Increase Medication Adherence

Speaking in an interview with CNBC on Tuesday, Dudum said an AI coach could remind patients to take their medicine, monitor side effects and even connect with healthcare providers.

vor 17 Stunden · Investing.com

Hims & Hers CEO pushes back against FTC suit, says "we are active disruptors"

Investing.com -- Hims & Hers Chief Executive Andrew Dudum defended the telehealth company against a Federal Trade Commission lawsuit concerning its data sharing practices in an interview that aired Tu...

vor 18 Stunden · Moby

Hims & Hers CEO Tells the FTC That Regulators Just Don’t Understand

Andrew Dudum explained CNBC that the FTC’s lawsuit is just a misunderstanding of what he’s doing... but maybe the regulator might understand him just fine?

vor 1 Tag · Stocktwits

HIMS Stock Has Quadrupled In 5 Years: How Hims Turned A $3 Stock Into A Telehealth Giant

CEO Andrew Dudum marked the company’s fifth listing anniversary by ringing the NYSE opening bell and declaring its “next phase of growth.”

Seite 1 von 2

Hims & Hers Health Inc. (HIMS)